Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00433030 |
Recruitment Status
:
Completed
First Posted
: February 9, 2007
Last Update Posted
: March 20, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Since 2004, the Thai Ministry of Public Health has massively scaled up antiretroviral treatment programs to provide therapy to more than 80,000 patients with partial support of the Global Fund to fight AIDS, Tuberculosis and Malaria (GFATM).
As access to HIV care continues to expand under the universal health coverage system, it is important to document and analyze the efficacy, tolerance, toxicity and acceptability of antiretroviral therapy within pilot treatment programs, to provide evidence based feedback and recommendations to the national program and policy makers.
Condition or disease |
---|
HIV Infections |
As Thailand is rapidly expanding access to antiretroviral treatments under the universal health coverage system, it is crucial to document and learn from pilot antiretroviral treatment programs, in particular the medical outcomes and logistical, and organizational issues faced by hospital teams and patients in order to adapt the ARV delivery and monitoring system to various local settings.
Specific objectives
- Analyze data collected in patients participating in the PHPT antiretroviral treatment program, in accordance to national and international guidelines, with no experimental interventions.
- To determine factors associated with treatment outcome including immune status, virologic factors and antiretroviral drugs levels
- To study the operational aspects of integrating comprehensive HIV care into the existing care system with regards to new activities generated at the hospital level (counseling, referral systems, biological monitoring), the impact on other health activities, mobilization of human and financial resources, affordability and sustainability.
The population of the study consists of approximately 2,000 consenting HIV-infected patients, including one-third of children, receiving HIV care as part of the GF-ATM or OXFAM Access to Antiretroviral programs, presenting at any of the PHPT network hospitals.
Study Type : | Observational |
Actual Enrollment : | 2816 participants |
Observational Model: | Cohort |
Time Perspective: | Prospective |
Official Title: | Observational Cohort of HIV Infected Adults and Children in the PHPT Network Hospitals in Thailand |
Study Start Date : | January 2007 |
Actual Primary Completion Date : | February 2018 |
Actual Study Completion Date : | February 2018 |

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
-
Adults and children (children are defined as less than 18 years old) patients are eligible for the inclusion in the cohort if they meet all the following inclusion criteria:
- Participation in the GFATM or Oxfam Access to Antiretroviral Programs
- For adults, consent to have their clinical or biological data used for this research study, and willingness to be followed at one of the PHPT network hospitals. For children, caregiver's consent to participate, willingness to bring the child to the scheduled visits for the duration of the treatment, and to have the child's clinical or biological data used for this research study.
Exclusion Criteria:
- This is an observational study of an access to treatment program, therefore all patients who require treatment and are willing to be followed by the medical team and have their data collected can be enrolled in the study. The only exclusion criteria would be refusal to participate and the discontinuation criteria would be withdrawal of consent.

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00433030
Thailand | |
Doi Saket Hospital | |
Doi Saket, Chiang Mai, Thailand | |
Mae on Hospital | |
Mae on, Chiang Mai, Thailand | |
Nakornping Hospital | |
Mae Rim, Chiang Mai, Thailand | |
San Kamphaeng Hospital | |
San Kamphaeng, Chiang Mai, Thailand | |
Sanpatong Hospital | |
San Pa Tong, Chiang Mai, Thailand, 50120 | |
San Sai Hospital | |
San Sai, Chiang Mai, Thailand | |
Mae Chan Hospital | |
Mae Chan, Chiang Rai, Thailand | |
Mae Sai Hospital | |
Mae Sai, Chiang Rai, Thailand | |
Phan Hospital | |
Phan, Chiang Rai, Thailand | |
Chiangrai Prachanukroh Hospital | |
Chiang Rai, Chiangrai, Thailand | |
Somdej Pranangchao Sirikit Hospital | |
Sattahip, Chonburi, Thailand | |
Kranuan Crown Prince Hospital | |
Kranuan, Khon Kaen, Thailand | |
Mahasarakam Hospital | |
Maha Sarakham, Mahasarakam, Thailand | |
Nakhonpathom Hospital | |
Nakhon Pathom, Nakhonpathom, Thailand | |
Chiang Kham Hospital | |
Chiang Kham, Phayao, Thailand | |
Hat Yai Hospital | |
Hat Yai, Songkla, Thailand | |
Bhumibol Adulyadej Hospital | |
Bangkok, Thailand | |
Nopparat Rajathanee Hospital | |
Bangkok, Thailand | |
Somdej Prapinklao Hospital | |
Bangkok, Thailand | |
Chacheongsao Hospital | |
Chachoengsao, Thailand | |
Prapokklao Hospital | |
Chanthaburi, Thailand | |
Chonburi Hospital | |
Chon Buri, Thailand | |
Kalasin Hospital | |
Kalasin, Thailand | |
Phaholpolphayuhasena Hospital | |
Kanchanaburi, Thailand | |
Khon Kaen Hospital | |
Khon Kaen, Thailand | |
Regional Health Promotion Centre 6, Khon Kaen | |
Khon Kaen, Thailand | |
Lampang Hospital | |
Lampang, Thailand | |
Lamphun Hospital | |
Lamphun, Thailand | |
Maharaj Nakornratchasrima Hospital | |
Nakhon Ratchasima, Thailand | |
Nong Khai Hospital | |
Nong Khai, Thailand | |
Pranangklao Hospital | |
Nonthaburi, Thailand | |
Phayao Provincial Hospital | |
Phayao, Thailand | |
Buddhachinaraj Hospital | |
Phitsanulok, Thailand | |
Ratchaburi Hospital | |
Ratchaburi, Thailand | |
Rayong Hospital | |
Rayong, Thailand | |
Roi-et Hospital | |
Roi-et, Thailand | |
Samutprakarn Hospital | |
Samut Prakan, Thailand | |
Samutsakon Hospital | |
Samut Sakhon, Thailand |
Principal Investigator: | Gonzague JOURDAIN, MD, PhD | Institut de Recherche pour le Developpement |
Additional Information:
Publications of Results:
Responsible Party: | GONZAGUE JOURDAIN, Senior Researcher, Institut de Recherche pour le Developpement |
ClinicalTrials.gov Identifier: | NCT00433030 History of Changes |
Other Study ID Numbers: |
PHPT-Cohort |
First Posted: | February 9, 2007 Key Record Dates |
Last Update Posted: | March 20, 2018 |
Last Verified: | March 2018 |
Keywords provided by GONZAGUE JOURDAIN, Institut de Recherche pour le Developpement:
Highly Active Antiretroviral Therapy HIV Viral load HIV drug Resistance Thailand |
Additional relevant MeSH terms:
HIV Infections Lentivirus Infections Retroviridae Infections RNA Virus Infections Virus Diseases |
Sexually Transmitted Diseases, Viral Sexually Transmitted Diseases Immunologic Deficiency Syndromes Immune System Diseases |